SecBot SecBot
PRESS-RELEASE ·Filed Jun 3, 2026

QUCY

Quantum Cyber
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

This is a narrative-building press release with no new hard catalysts. Monitor for conversion of LOIs into definitive contracts or patent issuance before assigning material value.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
QUCY ▼ -40.24% at T+60d
NEUTRAL call -40.24% · α vs SPY -42.74% · entry $2.46 → $1.47
Entry = T+0 close
Jun 3, 2026
via day close
T+1d
-5.28%
call -5.28% · α -5.68%
$2.33
settled 5mo ago
T+5d
-21.95%
call -21.95% · α -18.13%
$1.92
settled 5mo ago
T+20d
-41.06%
call -41.06% · α -40.06%
$1.45
settled 4mo ago
T+60d
-40.24%
call -40.24% · α -42.74%
$1.47
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Quantum Cyber published an inaugural corporate investor presentation consolidating previously announced milestones: LOIs with General Cherry and SOCOM, eight filed patent positions, and a clean balance sheet with zero debt and $15M in cash. The filing contains no new financial data, no definitive contracts, and no revenue — it is a marketing document.

Key Facts

  • Inaugural corporate investor presentation published; no new financial data or definitive agreements disclosed.
  • 22,767,254 shares outstanding, zero debt, zero warrants, $15M in cash from completed warrant exercises.
  • LOIs signed with General Cherry and SOCOM are non-binding; patent filings are provisional and not guaranteed to issue.
  • DAWG FY2027 budget request cited at $54.6B vs $225.9M FY2026 appropriation — a 242x increase — but this is a government budget proposal, not a company contract.
  • No revenue, earnings, or guidance figures provided in the press release.

Financial Impact

No financial impact quantified; company reports $15M cash, zero debt, zero revenue.

cashshares outstanding

Risk Factors

  • LOIs are non-binding and may not convert to revenue-generating contracts.
  • Provisional patent filings do not guarantee issued patents or commercial protection.
  • Company has no disclosed revenue; valuation is entirely based on future expectations.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3306018
35 reports for QUCY
Performance horizon
67% Hit rate @ T+20 4 of 6 directional calls Went positive at some point 5 of 7 best @ T+60▲ +39.06%Jun 4, 2026
Filters
Rows
Reports for QUCY — sortable, filterable
TypeNow
Oct 26, 2026
today
Press Release
NEUTRAL ★ 2/10
$1.03awaiting T+20—$0.8520 (−17.28%)
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 2/10
$1.07awaiting T+20—$0.8520 (−20.37%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$1.03awaiting T+20—$0.8520 (−17.28%)
Oct 9, 2026
17d ago
424B5
BEARISH ★ 7/10
$1.03awaiting T+20—$0.8520 (+17.28%)
Sep 28, 2026
28d ago
Press Release
NEUTRAL ★ 3/10
$1.36 $0.8515▼ −37.39%▼ −37.36%$0.8520 (−37.35%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$0.8520 (−37.81%)
Sep 25, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$0.8520 (−37.81%)
Aug 13, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$1.42 $1.34▼ −5.63%▼ −3.89%$0.8520 (−40.00%)
Jul 24, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$1.08 $1.30▲ +20.37%▲ +16.74%$0.8520 (−21.11%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 4/10
$1.19awaiting T+20—$0.8520 (−28.40%)
Showing 10 of 35

US Market Status

Market Closed — Opens in 3h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026